Measuring fatigue as a symptom in COPD: From descriptors and questionnaires to the importance of the problem

Chronic Respiratory Disease

Volumn 12, Issue 3, 2015, Pages 179-188

  Antoniu, Sabina Antonela ^a   Ungureanu, Didona ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

COPD; descriptors; fatigue; palliative care; scales

Indexed keywords

ANEMIA; ARTICLE; BRIEF FATIGUE INVENTORY; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; EDMONTON SYMPTOM ASSESSMENT SYSTEM; FATIGUE; FATIGUE ASSESSMENT SCALE; FATIGUE IMPACT SCALE; FATIGUE SEVERITY SCALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY SCALE FOR FATIGUE; FUNCTIONAL STATUS ASSESSMENT; HUMAN; HYPOXEMIA; IDENTITY CONSEQUENCE FATIGUE SCALE; INFLAMMATION; MANCHESTER COPD FATIGUE SCALE; MORTALITY; MULTIDIMENSIONAL ASSESSMENT OF FATIGUE; MULTIDIMENSIONAL FATIGUE INVENTORY; PATIENT REPORTED OUTCOME MEASUREMENT INFORMATION SYSTEM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SARCOPENIA; SHORT FORM 36; SYMPTOM ASSESSMENT; VISUAL ANALOG SCALE; COMPLICATION; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

FATIGUE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; SYMPTOM ASSESSMENT;

EID: 84937914668     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972315575716     Document Type: Article

References (61)

1. Breslin E, van der Schans C, Breukink S,. Perception of fatigue and quality of life in patients with COPD. Chest 1998; 114 (4): 958-964.
2. Minton O, Berger A, Barsevick A,. Cancer-related fatigue and its impact on functioning. Cancer 2013; 119: 2124-2130.
3. Evengard B, Komaroff AL,. Chronic fatigue syndrome does exist. Changes of biological parameters are measurable. Lakartidningen 1999; 96 (26-27): 3166-3169.
4. Evengard B, Nilsson CG, Lindh G,. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998; 78 (2): 153-155.
5. Green BN, Johnson CD, Adams A,. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med 2006; 5 (3): 101-117.
6. Ream E, Richardson A,. Fatigue: a concept analysis. Int J Nurs Stud 1996; 33 (5): 519-529.
7. Ream E, Richardson A,. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud 1997; 34 (1): 44-53.
8. Stridsman C, Lindberg A, Skar L,. Fatigue in chronic obstructive pulmonary disease: a qualitative study of peoples experiences. Scand J Caring Sci 2014; 28 (1): 130-138.
9. Al-Shair K, Kolsum U, Dockry R,. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011; 12: 3.
10. Bruera E, Kuehn N, Miller MJ,. The edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991; 7 (2): 6-9.
11. Zeng L, Koo K, Zhang L,. Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the edmonton symptom assessment system. Support Care Cancer 2012; 20 (5): 1037-1042.
12. Bedard G, Zeng L, Zhang L.,. Minimal clinically important differences in the edmonton symptom assessment system in patients with advanced cancer. J Pain Symptom Manage 2013; 46 (2): 192-200.
13. Walke LM, Byers AL, Mccorkle R,. Symptom assessment in community-dwelling older adults with advanced chronic disease. J Pain Symptom Managem 2006; 31 (1): 31-37.
14. Walke LM, Byers AL, Gallo WT,. The association of symptoms with health outcomes in chronically ill adults. J Pain Symptom Manage 2007; 33 (1): 58-66.
15. Krupp LB, Larocca NG, Muir-Nash J,. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archiv Neurol 1989; 46 (10): 1121-1123.
16. Inal-Ince D, Savci S, Saglam M,. Fatigue and multidimensional disease severity in chronic obstructive pulmonary disease. Multidiscip Respir Med 2010; 5 (3): 162-167.
17. Whitehead L,. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage 2009; 37 (1): 107-128.
18. Mendoza TR, Wang XS, Cleeland CS,. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85 (5): 1186-1196.
19. Doyle T, Palmer S, Johnson J,. Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. Int J Psychiatry Med 2013; 45 (2): 189-202.
20. Michielsen HJ, De Vries J, Van Heck GL,. Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res 2003; 54 (4): 345-352.
21. De Vries J, Michielsen H, Van Heck GL,. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 2004; 9 (Pt 3): 279-291.
22. Paddison JS, Booth RJ, Hill AG,. Comprehensive assessment of peri-operative fatigue: development of the identity-consequence fatigue scale. J Psychosom Res 2006; 60 (6): 615-622.
23. Paddison JS, Effing TW, Quinn S,. Fatigue in COPD: association with functional status and hospitalisations. Eur Respir J 2013; 41 (3): 565-570.
24. Fisk JD, Ritvo PG, Ross L,. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18 (Suppl 1): S79-S83.
25. Calik-Kutukcu E, Savci S, Saglam M,. A comparison of muscle strength and endurance, exercise capacity, fatigue perception and quality of life in patients with chronic obstructive pulmonary disease and healthy subjects: a cross-sectional study. BMC Pulm Med 2014; 14: 6.
26. Kos D, Kerckhofs E, Carrea I,. Evaluation of the modified fatigue impact scale in four different european countries. Mult Scler 2005; 11 (1): 76-80.
27. Smets EM, Garssen B, Bonke B,. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39 (3): 315-325.
28. Wong CJ, Goodridge D, Marciniuk DD,. Fatigue in patients with COPD participating in a pulmonary rehabilitation program. Int J Chron Obstruct Pulmon Dis 2010; 5: 319-326.
29. Belza B, Steele BG, Hunziker J,. Correlates of physical activity in chronic obstructive pulmonary disease. Nurs Res 2001; 50 (4): 195-202.
30. Webster K, Cella D, Yost K,. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 2003; 1: 79.
31. Al-Shair K, Muellerova H, Yorke J,. Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes 2012; 10: 100.
32. Brazier JE, Harper R, Jones NM,. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305 (6846): 160-164.
33. Limsuwat C, Mcclellan R, Amiri H,. Pulmonary rehabilitation improves only some domains of health-related quality of life measured by the Short Form-36 questionnaire. Ann Thorac Med 2014; 9 (3): 144-148.
34. Boueri FMV, Bucher-Bartelson BL, Glenn KA,. QUality of life measured with a generic instrument (short form-36) improves following pulmonary rehabilitation in patients with copd∗. Chest 2001; 119 (1): 77-84.
35. Jones PW, Bosh TK,. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155 (4): 1283-1289.
36. Baltzan MA, Scott AS, Wolkove N,. Fatigue in COPD: prevalence and effect on outcomes in pulmonary rehabilitation. Chron Respir Dis 2011; 8 (2): 119-128.
37. Lin FJ, Pickard AS, Krishnan JA,. Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5 L and PROMIS-43 short form. BMC Med Res Methodol 2014; 14: 78.
38. Guyatt GH, Berman LB, Townsend M,. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42 (10): 773-778.
39. Lewko A, Bidgood PL, Jewell A,. Evaluation of multidimensional COPD-related subjective fatigue following a pulmonary rehabilitation programme. Respir Med 2014; 108 (1): 95-102.
40. Al-Shair K, Kolsum U, Berry P,. Development, dimensions, reliability and validity of the novel manchester COPD fatigue scale. Thorax 2009; 64 (11): 950-955.
41. Revicki D, Meads DM, Mckenna SP,. COPD and asthma fatigue scale (CAFS): development and psychometric assessment. Health Outcomes Res Med 2010; 1 (1): e5-e16.
42. Amann M, Goodall S, Twomey R,. Altitudeomics: on the consequences of high-altitude acclimatization for the development of fatigue during locomotor exercise in humans. J Appl Physiol 2013; 115 (5): 634-642.
43. Eaton T, Garrett JE, Young P,. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. The Eur Respir J 2002; 20 (2): 306-312.
44. Eaton T, Lewis C, Young P,. Long-term oxygen therapy improves health-related quality of life. Respir Med 2004; 98 (4): 285-293.
45. Bower JE, Ganz PA, Aziz N,. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64 (4): 604-611.
46. Lasselin J, Laye S, Dexpert S,. Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes. Brain, Behav Immun 2012; 26 (8): 1211-1219.
47. Hodge G, Holmes M, Jersmann H,. Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD. BMC Pulmon Med 2014; 14: 85.
48. Antoniu SA,. Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease. Biomarkers 2010; 15 (2): 97-103.
49. Agusti A, Edwards LD, Rennard SI,. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PloS one 2012; 7 (5): e37483.
50. Janssen DJ, Mullerova H, Agusti A,. Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. Respir Med 2014; 108 (11): 1647-1654.
51. Bohlius J, Tonia T, Nuesch E,. Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data. Br J Cancer 2014; 111 (1): 33-45.
52. Yohannes AM, Ershler WB,. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care 2011; 56 (5): 644-652.
53. Silverberg DS, Mor R, Weu MT,. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulmon Med 2014; 14: 24.
54. Eid AA, Ionescu AA, Nixon LS,. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164 (8 Pt 1): 1414-1418.
55. Di Francia M, Barbier D, Mege JL,. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150 (5 Pt 1): 1453-1455.
56. Eagan TM, Gabazza EC, D'alessandro-Gabazza C,. TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients. Respir Res 2012; 13: 48.
57. Baghai-Ravary R, Quint JK, Goldring JJ,. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 2009; 103 (2): 216-223.
58. Kapella MC, Larson JL, Patel MK,. Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res 2006; 55 (1): 10-17.
59. Lewko A, Bidgood PL, Garrod R,. Evaluation of psychological and physiological predictors of fatigue in patients with COPD. BMC Pulmon Med 2009; 9: 47.
60. Stridsman C, Skär L, Hedman L,. Fatigue affects health status and predicts mortality among subjects with COPD: report from the population-based OLIN COPD study. COPD. Epub ahead of print 1 July 2014. http://informahealthcare.com/doi/abs/10.3109/15412555.2014.922176
61. Piper BF, Dibble SL, Dodd MJ,. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncology Nursing Forum 1998; 25 (4): 677-684.